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Introduction 
During passive heating of resting humans, minute ventilation (VE) changes little as esophageal 
temperature (Tes, an index of core temperature) rises until the temperature reaches about 38°C. 
Above this threshold, VE increases by ~30 L/min with respect to 1°C rise in Tes and results in a 
decrease in arterial CO2 pressure (PaCO2) (Tsuji et al. 2012). In nornothermic condition, 
generally, change in PaCO2 can affect both ventilatory and cerebrovascular responses such that 
the decrease in PaCO2 suppresses VE via central chemoreceptors, and also reduces cerebral 
blood flow by cerebral vasoconstriction. However, the effect of reduced PaCO2 on ventilatory 
and cerebrovascular responses during hyperthermia at rest is not well understood. We previously 
found that, during prolonged moderate exercise in the heat, restoration of PaCO2 to the eucapnic 
level augmented the ventilatory sensitivity to rising Tes (slope of the Tes-VE relation) by 
threefold (Hayashi et al. 2011). The present study thus examined the effect of PaCO2 on the 
ventilatory sensitivity and cerebrovascular response to rinsing Tes at rest. 
Methods 
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Fourteen healthy male were passively heated using hot-water immersion (41°C) and a 
water-perfused suit until Tes reached 39°C or the subjects could no longer tolerate the heating. 
During the heating on two separate occasions, subjects breathed room air (Control trial) or 
CO2-enriched air (a mixture of room air and 100% CO2) to prevent a reduction in PETCO2 (an 
index of PaCO2) (CO2 trial).  
Results and Discussion 
Tes threshold for increase in VE was seen at both trials (Control vs. CO2: 38.4±0.4 vs. 38.1±
0.6°C, P = 0.13), and above the thresholds VE increased linearly with rising Tes. In Control trial 
PETCO2 declined gradually with rising Tes above the threshold, whereas it in CO2 trial remained at 
eucapnic level. Ventilatory sensitivity to increasing Tes did not differ between Control and CO2 
trials (38.1±43.1 vs. 16.5±11.1 L/min/°C, P = 0.15). These suggest that ventilatory response 
with rising core temperature at rest is unaffected by a decrease in PaCO2. Middle cerebral artery 
mean blood velocity (MCAVmean) decreased gradually with rising Tes in Control trial (59.9 ± 8.4 
and 49.9 ±9.7 sm/s at Tes 36.8 and 38.8°C, respectively), and the reduced MCAVmean was 
restored by about 40% in CO2 trial (53.8 ± 5.6 cm/s at Tes 38.8°C), but inhaling CO2 had no 
significant effect on MCAVmean. Furthermore, the restoration of MCAVmean by CO2 inhalation 
was similar among each Tes revel of 37.2, 37.6, 38.0, 38.4 and 38.8°C. These suggest that the 
decrease in PaCO2 accounts for the reduction in MCAVmean by 40% at Tes range of 37–39°C 
during passive heating at rest.  
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